Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria
References
- Udeh EO, Duhlinska-Popova DD, Goselle ON and Abelau AM. Prevalence of intestinal protozoans in HIV/AIDS patients in Abuja, Nigeria. Science World Journal. 2008; 3(3): 1–4. DOI: 10.4314/swj.v3i3.51808
- Weber R, Bryan RRT, Owen RL, Wilcox CM, Gorelkin L and Visvesvara GS. Improved high microscopical detection of microsporidia spores in stool and duodenal aspirates. New England Journal of Medicine. 1992; 32: 61–166. DOI: 10.1056/NEJM199201163260304
- Sher A, Gazzinelli RT, Osward IP, et al. The role of T-Cell drives cytokines in the regulation of immune responses in parasitic and retroviral infection. Immunological Review. 1992; 127: 183–204. DOI: 10.1111/j.1600-065X.1992.tb01414.x
- Hunter G, Bagshawe AF, Babso KS, Luke R and Provic P. Intestinal parasites in Zambian patients with AIDS. Transactions of Royal Society of Tropical Medicine and Hygiene. 1992; 86: 543–554. DOI: 10.1016/0035-9203(92)90102-I
- World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2016; 2: 236–387.
- WHO. Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV infection: Recommendations for a Public Health Approach; 2013.
- WHO.
Scaling-up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach . Geneva; 2006. - Lyamuya E, Bredberg-Raadén U, Massawe A, Urassa E, Kawo G and Msemo G. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar-es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes. 1996; 12(4): 421–428. DOI: 10.1097/00042560-199608010-00014
- Federal Ministry of Health (FMOH). 2014 National HIV Sero-prevalence sentinel survey among pregnant women attending antenatal clinics in Nigeria, National AIDS/STI Control Programme, Federal Ministry of Health Nigeria; 2015.
- Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL and Francis D. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: A population-based study. Journal of Infectious Diseases. 2006; 193(1): 9–15. DOI: 10.1086/498577
- Morgan D, Malamba SS, Orem J, Mayanja B, Okongo M and Whitworth JA. Survival by AIDS defining condition in rural Uganda. Sexually Transmitted Infections. 2000; 76(3): 193–197. DOI: 10.1136/sti.76.3.193
- Grant AD, Djomand G, Smets P, Kadio A, Coulibaly M and Kakou A. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d’Ivoire. AIDS (London, England). 1997; 11(11): 1357–1364. DOI: 10.1097/00002030-199711000-00010
- Monjok E, Smesny A, Okokon IB, Mgbere O and Essien EJ. Adherence to antiretroviral therapy in Nigeria: An overview of research studies and implications for policy and practice. HIV/AIDS Research and Palliative care. 2010; 2: 69–76. DOI: 10.2147/HIV.S9280
- Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F and Kirchherr JL. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases. 2007; 45: 1492–1498. DOI: 10.1086/522991
- Chesney MA. (2006). The elusive gold standard: Future perspectives for HIV adherence assessment and intervention. Journal of Acquired Immune Deficiency Syndromes. 2006; 43(1): 3–9. DOI: 10.1097/01.qai.0000243112.91293.26
- Fätkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C and Becker K. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS. 1997; 11(14): 113–116. DOI: 10.1097/00002030-199714000-00001
- Lucas GM, Chaisson RE and Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine. 1999; 131: 81–87. DOI: 10.7326/0003-4819-131-2-199907200-00002
- Mitiku H, Weldegebreal F and Teklemariam Z. Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in Eastern Ethiopia. HIV/AIDS Research and Palliative Care. 2015; 7: 137–144. DOI: 10.2147/HIV.S79545
- Galisteu KJ, Cardoso LV, Furini AAC, et al. Opportunistic infections among individuals with HIV-1/AIDS in the highly active antiretroviral therapy era at a Quaternary Level Care Teaching Hospital. Revista da Sociedade Brasileira de Medicina Tropical. 2015; 48(2): 149–156. DOI: 10.1590/0037-8682-0299-2014
- Alemu F. Prevalence of intestinal parasites and other parasites among HIV/AIDS patients with on-ART attending Dilla Referral Hospital, Ethiopia. Journal of AIDS Clinical and Research. 2014; 5(9): 1–5. DOI: 10.4172/2155-6113.1000345
- Adamu H, Wegayehu T and Petros B. High prevalence of diarrhoegenic intestinal parasite infections among non-ART HIV patients in Fitche Hospital, Ethiopia. PLoS ONE. 2013; 8(8):
e72634 . DOI: 10.1371/journal.pone.0072634 - Sow PG, Coume M, Ndiaye PP, Boucal JC and Amousouguenou G. About intestinal parasitic infections in a cohort of HIV-infected patient. Advances in Bioresearch. 2012; 3(2): 32–35.
- Pavie J, Menotti J and Porcher R. Prevalence of opportunistic intestinal parasitic infections among HIV-infected patients with low CD+4 cells counts in France in the combination antiretroviral therapy era. International Journal of Infectious Diseases. 2012; 16(9): 677–679. DOI: 10.1016/j.ijid.2012.05.1022
- Devi SB and Robinson-Ningshen AG. Burden of Opportunistic Infections in HIV/AIDS patients in the highly active antiretroviral therapy era. A Regional Institute of Medical Sciences, Imphal Perspective; 2012.
- Hung CC and Chang SC. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. Journal of Antimicrobial Chemotherapy. 2004; 54: 849–853. DOI: 10.1093/jac/dkh438
- Foudraine NA, Weverling GJ and van-Gool T. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS. 1998; 12: 35–41. DOI: 10.1097/00002030-199801000-00005
- Carr A, Marriot D and Field A. Treatment of HIV-1 associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet. 1998; 351: 256–261. DOI: 10.1016/S0140-6736(97)07529-6
- Tay SCK, Aryee ENO and Badu K. Intestinal parasitemia and HIV/AIDS co-infections at varying CD4+ T-cell levels. HIV/AIDS Research and Treatment Open Journal. 2017; 4(1): 40–48. DOI: 10.17140/HARTOJ-4-126
- Akinbo FO, Okaka CE and Omoregie R. Prevalence of intestinal parasitic infections among HIV patients in Benin City, Nigeria. Libyan Journal of Medicine. 2010; 5: 1–6. DOI: 10.3402/ljm.v5i0.5506
DOI: https://doi.org/10.5334/aogh.2554 | Journal eISSN: 2214-9996
Language: English
Published on: Jul 5, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2019 Emmanuel Ochigbo Udeh, R. N. N. Obiezue, F. C. Okafor, C. B. Ikele, I. C. Okoye, Chidiebere A. Otuu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.